Mataró, Barcelona, Spain, and Düsseldorf, Germany, 09 September 2026 - Minoryx Therapeutics and Neuraxpharm Group (Neuraxpharm), announce that the last patient has been enrolled in the global Phase 3 clinical...
Art Pappas will be on a panel titled "Update on Capital Availability for Indiana Companies" at Burrill's Indiana Life Sciences Forum in Indianapolis, IN
News | 10. 21. 2008
